Sorbentogel (methyl silicic acid hydrogel) oral gel 0.7 g/g. 270 g. vial

Description

Sorbentogel (methyl silicic acid hydrogel) oral gel 0.7 g/g. 270 g. vial

Composition

active substance: methyl silicic acid hydrogel;

1 g of the drug contains a hydrogel of methyl silicic acid 0.7 g;

excipient: purified water.

Dosage form

Oral gel.

Main physical and chemical properties: homogeneous gel-like mass from white to almost white odorless.

Pharmacotherapeutic group

Drugs that affect the digestive system and metabolism. Antidiarrheal drugs, drugs used to treat infectious and inflammatory bowel diseases. Enterosorbents. Other enterosorbents.
ATX code A07B C.

Pharmacological properties

It is an enterosorbent – a means that binds toxic substances of various natures, products of incomplete metabolism, incorporated radionuclides, causative agents of diseases in the gastrointestinal tract, with subsequent excretion from the body in a natural way. Absorbs toxic substances that are formed in the gastrointestinal tract, as well as those that have entered the digestive tract from the environment. In addition, the drug prevents the reabsorption of toxic substances released into the lumen of the intestine from the blood or entered with bile, binds and removes rotaviruses, pathogenic bacteria. Eliminates the manifestations of toxicosis, normalizes the indices of urine and blood, improves the function of the intestines, kidneys, liver.

Indications

Sorbentogel oral gel is used:

• as part of complex detoxification therapy for toxic hepatitis, chronic renal failure, viral hepatitis, cholestasis of various etiologies, liver cirrhosis, colitis, enterocolitis, diarrhea, gastritis with low acidity;
• in case of poisoning with drugs, alcohol;
• with allergic, skin diseases (neurodermatitis, diathesis);
• with toxicosis of the first half of pregnancy;
• with inflammatory, purulent-septic processes, accompanied by severe intoxication;
• with burn intoxication;
• in the complex therapy of intestinal dysbiosis.

Contraindications

Sorbentogel is not used:

• with intolerance to the components;
• with acute intestinal obstruction.

Application during pregnancy and lactation

Sorbentogel can be used by pregnant and breastfeeding women. Use should be limited in pregnant women with a tendency to constipation.

Method of administration and dosage

Sorbentogel oral gel is used orally three times a day for 1.5-2 hours before or two hours after meals, medication. The drug should be taken with plenty of water.
A single dose for adults, children from 14 years old is 15 g (one tablespoon), the daily dose is 45 g.
Single dose for children from birth to 5 years old – 5 g (one teaspoon), daily dose – 15 g. Single dose for children 5-14 years old – 10 g (one dessert spoon), daily dose – 30 g.
The standard course of treatment is 7-14 days.
In a severe course of the disease, it is allowed to use a double single dose in the first three days, and in a chronic course (for example, with chronic renal failure), a longer use of the drug is allowed (up to one month).

Overdose

Overdose may increase the side effects described below.
If the dose is significantly exceeded or signs of an overdose are detected, it is recommended to stop taking the drug and seek medical help.
Treatment of an overdose involves discontinuing the drug, taking a large amount of liquid, symptomatic therapy.

Side effects

In the first days of admission, it is possible to develop constipation, dyspeptic symptoms. To prevent constipation in the first two days of admission, it is recommended to carry out a cleansing enema at night or to prescribe laxatives (sodium picosulfate, lactulose).